Literature DB >> 9740099

Neural activation of the brain with hemodynamic insufficiency.

S Inao1, M Tadokoro, M Nishino, N Mizutani, K Terada, M Bundo, H Kuchiwaki, J Yoshida.   

Abstract

Little is known about how ischemia affects hemodynamic responses to neural activation in the brain. We compare the effects of a motor activation task and a cerebral vasodilating agent, acetazolamide (ACZ), on regional cerebral blood flow (rCBF) in primary sensorimotor cortex (PSM) in six patients with major cerebral artery steno-occlusive lesions without paresis of the upper extremities. Quantitative rCBF was measured in all patients using H2(15)O autoradiographic method and positron emission tomography. The CBF was determined at rest, during a bimanual motor activation task, and 10 minutes after ACZ administration. With bimanual motor activation, rCBF increased significantly in both PSM compared with at rest (P < 0.01 on lesion side, and P < 0.02 on contralateral side). However, rCBF did not increase after ACZ injection in the PSM on the lesion side, whereas rCBF increased significantly in the contralateral PSM after ACZ injection compared with the level at rest. This result suggests that despite a decreased hemodynamic reserve, there is a nearly normal flow response to neural activation, indicating that the mechanism of vasodilation responsible for perfusion change is different for acetazolamide and neural activation. The relations among neural activation, hemodynamic status, and cerebral metabolism in the ischemic stroke patients are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9740099     DOI: 10.1097/00004647-199809000-00005

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  8 in total

1.  Hemodynamic impairment and stroke risk: prove it.

Authors:  C P Derdeyn
Journal:  AJNR Am J Neuroradiol       Date:  2001-02       Impact factor: 3.825

2.  Correlation between brain reorganization, ischemic damage, and neurologic status after transient focal cerebral ischemia in rats: a functional magnetic resonance imaging study.

Authors:  Rick M Dijkhuizen; Aneesh B Singhal; Joseph B Mandeville; Ona Wu; Elkan F Halpern; Seth P Finklestein; Bruce R Rosen; Eng H Lo
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

Review 3.  Cerebral vascular dysregulation in the ischemic brain.

Authors:  Alexander Kunz; Costantino Iadecola
Journal:  Handb Clin Neurol       Date:  2009

4.  Changes in cortical microvasculature during misery perfusion measured by two-photon laser scanning microscopy.

Authors:  Yosuke Tajima; Hiroyuki Takuwa; Daisuke Kokuryo; Hiroshi Kawaguchi; Chie Seki; Kazuto Masamoto; Yoko Ikoma; Junko Taniguchi; Ichio Aoki; Yutaka Tomita; Norihiro Suzuki; Iwao Kanno; Naokatsu Saeki; Hiroshi Ito
Journal:  J Cereb Blood Flow Metab       Date:  2014-05-21       Impact factor: 6.200

5.  PET in Cerebrovascular Disease.

Authors:  William J Powers; Allyson R Zazulia
Journal:  PET Clin       Date:  2010-01-01

Review 6.  Hemodynamics and oxygen extraction in chronic large artery steno-occlusive disease: Clinical applications for predicting stroke risk.

Authors:  Colin P Derdeyn
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-19       Impact factor: 6.200

7.  Neurovascular regulation in the ischemic brain.

Authors:  Katherine Jackman; Costantino Iadecola
Journal:  Antioxid Redox Signal       Date:  2015-01-10       Impact factor: 8.401

8.  Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease.

Authors:  David F Moore; Gheona Altarescu; Peter Herscovitch; Raphael Schiffmann
Journal:  BMC Neurol       Date:  2002-06-18       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.